[DOI] [PubMed] [Google Scholar] 62.De Luca A., Mei G., Rosato N., Nicolai E., Federici L., Palumbo C., Pastore A., Serra M., Caccuri A.M
Its a promising option that could lead to symptom reduction and even remission
Glucagon-receptor activation contributes effects on hepatic lipid metabolism and whole-body energy expenditure that are absent from GLP-1 mono-agonists and dual GLP-1/GIP agonists
49: 463468, doi: Ringseis R, Keller J, Eder K
Evidence from RCTs for the use of B12 in other types of neuropathies is scarce, although non-randomised/uncontrolled studies have shown some benefits
Despite the benefit of this treatment, bleeding complications are frequent and intracranial hemorrhage is one of the most serious that can occur